EVT-401
/ Evotec, Conba
- LARVOL DELTA
Home
Next
Prev
1 to 2
Of
2
Go to page
1
February 09, 2018
Identification and characterization of related substances in EVT-401 by hyphenated LC-MS techniques.
(PubMed, J Pharm Anal)
- "Fourteen RSs including six process-related substances and eight degradation products were detected and identified in EVT-401 with positive ESI high-resolution TOF-MS analysis of their parent ions and the corresponding product mass spectra elucidation, and some of them were further verified by chemical synthesis and NMR spectroscopy. The specific LC-MS method developed for separation, identification and characterization of RSs is valuable for EVT-401 manufacturing process optimization and quality control."
Journal • Biosimilar • Multiple Sclerosis
August 08, 2012
Evotec H1 2012: Building innovation on the back of profitable growth
(Globenewswire)
- Evotec partnered in China with Conba especially for inflammation and endometriosis pain in April 2012 for EVT 401 a P2X7 antagonist
Licensing / partnership • Pain
1 to 2
Of
2
Go to page
1